Documenting and harnessing the biological potential of molecules in Distributed Drug Discovery (D3) virtual catalogs

5 years ago

Documenting and harnessing the biological potential of molecules in Distributed Drug Discovery (D3) virtual catalogs

William L. Scott, Milata M. Abraham, Richard W. Harper, Ryan E. Denton, Martin J. O'Donnell, Jacob D. Durrant

Virtual molecular catalogs have limited utility if member compounds are (i) difficult to synthesize or (ii) unlikely to have biological activity. The Distributed Drug Discovery (D3) program addresses the synthesis challenge by providing scientists with a free virtual D3 catalog of 73,024 easy-to-synthesize N-acyl unnatural α-amino acids, their methyl esters, and primary amides. The remaining challenge is to document and exploit the bioactivity potential of these compounds. In the current work, a search process is described that retrospectively identifies all virtual D3 compounds classified as bioactive hits in PubChem-cataloged experimental assays. The results provide insight into the broad range of drug-target classes amenable to inhibition and/or agonism by D3-accessible molecules. To encourage computer-aided drug discovery centered on these compounds, a publicly available virtual database of D3 molecules prepared for use with popular computer docking programs is also presented. The Distributed Drug Discovery (D3) program provides scientists with a free virtual catalog of 73,024 easy-to-synthesize N-acyl unnatural α-amino acids, their methyl esters, and primary amides. In the current work, we identify all virtual D3 compounds classified as bioactive hits in PubChem-cataloged experimental assays. The results (i) provide insight into the broad range of drug-target classes amenable to modulation by D3-accessible molecules and (ii) suggest future avenues for virtual screening/drug discovery projects.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/cbdd.13012